CASP9 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Inflammatory Breast Cancer

BACKGROUND: Inflammatory breast cancer (IBC) is one of the most rare and aggressive subtypes of primary breast cancer (BC). Our study aimed to explore hub genes related to the pathogenesis of IBC, which could be considered as novel molecular biomarkers for IBC diagnosis and prognosis. Material and M...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mingdi, Wu, Kejin, Wang, Maoli, Bai, Fang, Chen, Hongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527435/
https://www.ncbi.nlm.nih.gov/pubmed/36199443
http://dx.doi.org/10.1155/2022/1043445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527435/
https://www.ncbi.nlm.nih.gov/pubmed/36199443
http://dx.doi.org/10.1155/2022/1043445

Ejemplares similares